Mahai Chris LaVictoire
Transaction: 06/09/2026
OTHER
Change
0
Price
Not reported
Filing
06/11/2026
Type
OTHER
Abrdn Healthcare Investors
HQH • Asset Management
$22.56
▼ -0.09 (-0.40%)
Current price
EarningsLatest report: Dec 31, 2025
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$1.24B
Growth
36.7%
Cash Flow
0/5
Trend
Negative
Evidence
Stable or improving margins · 98.8%Positive revenue growth · 90.0%Reasonable earnings multiple · 10.3Manageable debt level · 0Healthy liquidity · 2.15
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Dec 31, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$22.56
Change-0.40%
Shares Out54.79M
Market Cap$1.24B
Enterprise Value$1.24B
52W Range15.09 - 20.46
Beta0.76
P/E3.73
P/S38.07
P/B1.13
P/FCF141.80
EV/Sales38.07
Price$22.56
Change-0.40%
Shares Out54.79M
Market Cap$1.24B
Enterprise Value$1.24B
52W Range15.09 - 20.46
Beta0.76
P/E3.73
P/S38.07
P/B1.13
P/FCF141.80
EV/Sales38.07
EV/EBITDA7.13
EV/FCF141.80
Earnings Yield26.83%
FCF Yield0.71%
Dividend Yield14.24%
Gross Margin100.00%
Oper. Margin98.80%
Profit Margin98.80%
Debt/Eq0.00
Current Ratio2.15
Quick Ratio2.15
Revenue 5Y36.68%
Volume129.24K
Avg Volume143.33K
Investment DNA
How strong this company looks for long-term investors
68
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
71/100
Why this score▼
Stable or improving margins · 98.8%Positive revenue growth · 90.0%Reasonable earnings multiple · 10.3Manageable debt level · 0Healthy liquidity · 2.15
Analyst view
No analyst data available now.
Insider Transactions
Recent executive and insider activity
Reilly Heather Carter
Transaction: 12/09/2025
OTHER
Change
0
Price
Not reported
Filing
12/19/2025
Type
OTHER
Dietrick Joseph Francis
Transaction: 07/17/2025
OTHER
Change
0
Price
Not reported
Filing
07/22/2025
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Mahai Chris LaVictoire | OTHER | 0 | Not reported | 06/09/2026 | 06/11/2026 |
| Reilly Heather Carter | OTHER | 0 | Not reported | 12/09/2025 | 12/19/2025 |
| Dietrick Joseph Francis | OTHER | 0 | Not reported | 07/17/2025 | 07/22/2025 |
| Kim Andrew Wonil | OTHER | 0 | Not reported | 03/11/2025 | 03/20/2025 |
| Taggart Michael | OTHER | 0 | Not reported | 03/11/2025 | 03/20/2025 |
| Marsico Michael | OTHER | 0 | Not reported | 03/11/2025 | 03/20/2025 |
| Hasson Heather | OTHER | 0 | Not reported | 03/11/2025 | 03/20/2025 |
| Gebauer Katie Lynn | OTHER | 0 | Not reported | 03/11/2025 | 03/20/2025 |
| Hepp Robert W. | OTHER | 0 | Not reported | 03/11/2025 | 03/20/2025 |
| Wilson Ashton | OTHER | 0 | Not reported | 12/10/2024 | 12/20/2024 |
| Silue Kolotioloma | OTHER | 0 | Not reported | 03/13/2024 | 12/20/2024 |
| DiMartino Rose | BUY | +1,000 | $18.88 | 07/16/2024 | 07/18/2024 |
| Taggart Michael | OTHER | 0 | Not reported | 06/12/2024 | 06/18/2024 |
| Nichols Rebecca Suzanne | SELL | 0 | Not reported | 06/10/2024 | 06/18/2024 |
| Goetz Kathleen | BUY | +525 | $16.42 | 04/09/2024 | 04/12/2024 |
| Tse Loretta | OTHER | 0 | Not reported | 03/13/2024 | 03/22/2024 |
| Goodson Alan R | BUY | +170 | $16.13 | 12/21/2023 | 01/09/2024 |
| Reit Todd | BUY | +1,000 | $16.93 | 01/02/2024 | 01/04/2024 |
| Maher Bill | BUY | +1,000 | $16.58 | 12/28/2023 | 01/02/2024 |
| Ritchie Ben | OTHER | 0 | Not reported | 12/13/2023 | 12/22/2023 |